Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling
Investment supports platform innovation, commercial scaling, and new service development; Infinity acquires the assets of Serimmune, Inc. BALTIMORE–(BUSINESS WIRE)–Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful…